Ausgabe 5/2015
Inhalt (17 Artikel)
Cancer active targeting by nanoparticles: a comprehensive review of literature
Remon Bazak, Mohamad Houri, Samar El Achy, Serag Kamel, Tamer Refaat
MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation
Xiushan Zheng, Jiaqiang Dong, Taiqian Gong, Zhiyong Zhang, Ying Wang, Yunming Li, Yulong Shang, Kai Li, Gui Ren, Bin Feng, Juntang Li, Qifei Tian, Shanhong Tang, Li Sun, Mengbin Li, Hongwei Zhang, Daiming Fan
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
K. Söderlund Leifler, A. Asklid, T. Fornander, M. Stenmark Askmalm
Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells
Kun Wang, Bin Wang, Ai Yan Xing, Ke Sen Xu, Guang Xin Li, Zhen Hai Yu
Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation
Franziska Mußbach, Petra Henklein, Martin Westermann, Utz Settmacher, Frank-D. Böhmer, Roland Kaufmann
LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme
Yong Yan, Lei Zhang, Ying Jiang, Tao Xu, Qiyong Mei, Hongxiang Wang, Rong Qin, Yongxiang Zou, Guohan Hu, Juxiang Chen, Yicheng Lu
Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)
Leonard Christopher Schmeel, Frederic Carsten Schmeel, Christoph Coch, Ingo G. H. Schmidt-Wolf
Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility
P. Mota, H. C. Silva, M. J. Soares, A. Pego, M. Loureiro, C. Robalo Cordeiro, F. J. Regateiro
Management of hepatocellular carcinoma
P. Fitzmorris, M. Shoreibah, B. S. Anand, A. K. Singal
Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation
Claudia Seifert, Susan Wittig, Clemens Arndt, Bernd Gruhn
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
Katerina Machova Polakova, Vojtech Kulvait, Adela Benesova, Jana Linhartova, Hana Klamova, Monika Jaruskova, Caterina de Benedittis, Torsten Haferlach, Michele Baccarani, Giovanni Martinelli, Tomas Stopka, Thomas Ernst, Andreas Hochhaus, Alexander Kohlmann, Simona Soverini
Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer
Min-Li Mo, Jie Ma, Zhao Chen, Bing Wei, Hui Li, Yong Zhou, Huaiyin Shi, Bhairavi Tolani, Joy Q. Jin, Hsin-Hui Tseng, Dong Shen, Yi Zhan, Jun Li, David M. Jablons, Rong-Qing Zhang, Yongjun Guo, Biao He, Hai-Meng Zhou
Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
Shaodong Hong, Min Tan, Shouzheng Wang, Shengyuan Luo, Yue Chen, Li Zhang
First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database
Christoph Oing, Anja Lorch, Carsten Bokemeyer, Friedemann Honecker, Jörg Beyer, Lars Arne Berger, Karin Oechsle
The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients
Yousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, Naminatsu Takahara, Kei Saito, Kazunaga Ishigaki, Tsuyoshi Hamada, Suguru Mizuno, Koji Miyabayashi, Keisuke Yamamoto, Dai Mohri, Hirofumi Kogure, Natsuyo Yamamoto, Hideaki Ijichi, Keisuke Tateishi, Minoru Tada, Kazuhiko Koike
A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy
Longsheng Miao, Haiquan Chen, Jiaqing Xiang, Yawei Zhang
Evaluation of chemotherapeutics in a three-dimensional breast cancer model
Carrie J. Lovitt, Todd B. Shelper, Vicky M. Avery